Tumor Size and Effectiveness of Electrochemotherapy

Overview

Journal Radiol Oncol

Publisher Sciendo

Specialties Oncology
Radiology

Date 2013 Mar 2

PMID 23450195

Citations 33

Authors

Barbara Mali

Damijan Miklavcic

Luca G Campana

Maja Cemazar

Gregor Sersa

Marko Snoj

Tomaz Jarm

Affiliations

Soon will be listed here.

Abstract

Background: Electrochemotherapy (ECT) is an effective and safe method for local treatment of tumors. However, relatively large variability in effectiveness of ECT has been observed, which likely results from different treatment conditions and tumor characteristics. The aim of this study was to investigate the relationship between tumor size and effectiveness of a single-session ECT.

Materials And Methods: A systematic search of various bibliographic databases was performed and nine studies eligible for this study were extracted. Different statistical methods including meta-analysis were applied to analyze the data.

Results: The results of analysis based on data from 1466 tumors of any histotype show significantly lower effectiveness of ECT on tumors with maximal diameter equal to or larger than 3 cm (complete response (CR) of 33.3%, objective response (OR) of 68.2%) in comparison to smaller tumors (CR% of 59.5%, OR% of 85.7%). The results of meta-analysis indicated that ECT performed on tumors smaller than 3 cm statistically significantly increases the probability of CR by 31.0% and OR by 24.9% on average in comparison to larger tumors. The analysis of raw data about the size and response of tumors showed statistically significant decrease in effectiveness of ECT progressively with increasing tumor diameter. The biggest drop in CR% was detected at tumor diameters as small as 2 cm.

Conclusions: The standard operating procedures for ECT should be reexamined and refined for the treatment of large tumors. We propose that future clinical trials should include accurate ECT treatment planning and/or multiple ECT cycles, besides a prolonged observation for tumor response evaluation.

Citing Articles

Influences of pulsed electric field parameters on cell electroporation and electrofusion events: Comprehensive understanding by experiments and molecular dynamics simulations.

Qu S, Ke Q, Li X, Yu L, Huang S PLoS One. 2025; 20(1):e0306945.

PMID: 39841685 PMC: 11753653. DOI: 10.1371/journal.pone.0306945.

Veterinary Guidelines for Electrochemotherapy of Superficial Tumors.

Tellado M, Mir L, Maglietti F Front Vet Sci. 2022; 9:868989.

PMID: 35968026 PMC: 9363792. DOI: 10.3389/fvets.2022.868989.

Malignant Skin Cancer Excision in Combined Therapy with Electro-Chemotherapy and Dermal Substitute.

De Angelis B, Balzani A, Pagnotta A, Tati E, Orlandi F, DAutilio M Curr Oncol. 2021; 28(3):1718-1727.

PMID: 34063113 PMC: 8161833. DOI: 10.3390/curroncol28030160.

A Retrospective Multicentric Study of Electrochemotherapy in the Treatment of Feline Nasal Planum Squamous Cell Carcinoma.

Simcic P, Pierini A, Lubas G, Lowe R, Granziera V, Tornago R Vet Sci. 2021; 8(3).

PMID: 33809822 PMC: 8004260. DOI: 10.3390/vetsci8030053.

A Prospective Phase II Study Evaluating Intraoperative Electrochemotherapy of Hepatocellular Carcinoma.

Djokic M, Cemazar M, Bosnjak M, Dezman R, Badovinac D, Miklavcic D Cancers (Basel). 2020; 12(12).

PMID: 33333941 PMC: 7765454. DOI: 10.3390/cancers12123778.

References

Alberts D, Chen H, Liu R, Himmelstein K, Mayersohn M, Perrier D . Bleomycin pharmacokinetics in man. I. Intravenous administration. Cancer Chemother Pharmacol. 1978; 1(3):177-81. DOI: 10.1007/BF00253118. View

Adeyanju O, Al-Angari H, Sahakian A . The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma. Radiol Oncol. 2012; 46(2):126-35. PMC: 3472940. DOI: 10.2478/v10019-012-0026-y. View

Domenge C, Orlowski S, Luboinski B, de Baere T, Schwaab G, BELEHRADEK Jr J . Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer. 1996; 77(5):956-63. DOI: 10.1002/(sici)1097-0142(19960301)77:5<956::aid-cncr23>3.0.co;2-1. View

Jarm T, Cemazar M, Miklavcic D, Sersa G . Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther. 2010; 10(5):729-46. DOI: 10.1586/era.10.43. View

Mir L, Tounekti O, Orlowski S . Bleomycin: revival of an old drug. Gen Pharmacol. 1996; 27(5):745-8. DOI: 10.1016/0306-3623(95)02101-9. View

Cemazar M, Milacic R, Miklavcic D, Dolzan V, Sersa G . Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content. Anticancer Drugs. 1999; 9(6):525-30. DOI: 10.1097/00001813-199807000-00002. View

Therasse P, Arbuck S, Eisenhauer E, Wanders J, Kaplan R, Rubinstein L . New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000; 92(3):205-16. DOI: 10.1093/jnci/92.3.205. View

Landstrom F, Nilsson C, Crafoord S, Reizenstein J, Adamsson G, Lofgren L . Electroporation therapy of skin cancer in the head and neck area. Dermatol Surg. 2010; 36(8):1245-50. DOI: 10.1111/j.1524-4725.2010.01617.x. View

Front D, Israel O, Iosilevsky G, Even-Sapir E, Ben-Haim S, Frenkel A . Administered dose and tumor dose of bleomycin labeled with cobalt-57 in mice and men. J Nucl Med. 1990; 31(11):1784-90. View

10.

Testori A, Faries M, Thompson J, Pennacchioli E, Deroose J, van Geel A . Local and intralesional therapy of in-transit melanoma metastases. J Surg Oncol. 2011; 104(4):391-6. DOI: 10.1002/jso.22029. View

11.

Edhemovic I, Gadzijev E, Brecelj E, Miklavcic D, Kos B, Zupanic A . Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat. 2011; 10(5):475-85. PMC: 4527414. DOI: 10.7785/tcrt.2012.500224. View

12.

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700. PMC: 2714672. DOI: 10.1136/bmj.b2700. View

13.

Larkin J, Collins C, Aarons S, Tangney M, Whelan M, OReily S . Electrochemotherapy: aspects of preclinical development and early clinical experience. Ann Surg. 2007; 245(3):469-79. PMC: 1877027. DOI: 10.1097/01.sla.0000250419.36053.33. View

14.

Miklavcic D, Towhidi L . Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells. Radiol Oncol. 2012; 44(1):34-41. PMC: 3423672. DOI: 10.2478/v10019-010-0002-3. View

15.

Quaglino P, Mortera C, Osella-Abate S, Barberis M, Illengo M, Rissone M . Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol. 2008; 15(8):2215-22. DOI: 10.1245/s10434-008-9976-0. View

16.

Matthiessen L, Chalmers R, Sainsbury D, Veeramani S, Kessell G, Humphreys A . Management of cutaneous metastases using electrochemotherapy. Acta Oncol. 2011; 50(5):621-9. PMC: 3130997. DOI: 10.3109/0284186X.2011.573626. View

17.

Hall S, Strong J, Broughton A, Frazier M, Benjamin R . Bleomycin clinical pharmacology by radioimmunoassay. Cancer Chemother Pharmacol. 1982; 9(1):22-5. DOI: 10.1007/BF00296756. View

18.

Pavliha D, Kos B, Zupanic A, Marcan M, Sersa G, Miklavcic D . Patient-specific treatment planning of electrochemotherapy: procedure design and possible pitfalls. Bioelectrochemistry. 2012; 87:265-73. DOI: 10.1016/j.bioelechem.2012.01.007. View

19.

Snoj M, Rudolf Z, Cemazar M, Jancar B, Sersa G . Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. Anticancer Drugs. 2005; 16(3):345-8. DOI: 10.1097/00001813-200503000-00015. View

20.

Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G . The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J. 1998; 74(5):2152-8. PMC: 1299558. DOI: 10.1016/S0006-3495(98)77924-X. View